{{Rsnum
|rsid=4784227
|Gene=LOC643714
|Chromosome=16
|position=52565276
|Orientation=plus
|GMAF=0.2181
|Gene_s=PLSCR3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 59.3 | 35.4 | 5.3
| HCB | 60.0 | 28.9 | 11.1
| JPT | 56.2 | 39.3 | 4.5
| YRI | 91.0 | 9.0 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 60.0 | 28.9 | 11.1
| CHD | 53.3 | 37.4 | 9.3
| GIH | 63.6 | 31.3 | 5.1
| LWK | 89.8 | 10.2 | 0.0
| MEX | 50.0 | 39.7 | 10.3
| MKK | 85.2 | 14.2 | 0.6
| TSI | 54.9 | 38.2 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20585626
|Title=Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia breast cancer consortium

The adjusted odds ratio for [[breast cancer]] risk was 1.25 (CI: 1.20?1.31) per [[rs4784227]](T) allele (p = 3.2×10e?25) in the pooled analysis of of over 10,000 samples from all Asian samples, and 1.19 (CI: 1.09-1.31, p = 1.3x10e-4) among European Americans (2,797 cases and 2,662 controls).

|OA=1
}}

{{PMID Auto
|PMID=21445572
|Title=Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies
}}

{{PMID Auto
|PMID=22452962
|Title=A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|OA=1
}}

{{PMID Auto
|PMID=23001124
|Title=Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}